MedTrace Logo

Malnutrition in Older Adults: An Intervention Based on Medication Review and Individual Nutritional Plan

NCT04228900 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-06-04

No results posted yet for this study

Summary

The project "Nutrition and Medication management in home-dwelling older adults" consist of two separate studies witch are described in the same study protocol. This is the second study in this Project. The first study (cross sectional) is described separately; Identification: 2017/12883-1

Undernutrition is common in older adults. The causes are many and include drug therapy. Drug side effects, as loss of appetite, nausea, or dry mouth, may contribute to malnutrition, impaired health and loss of function.

In patients with malnutrition or at risk for malnutrition we will evaluate an intervention consisting of:

* an "individual nutritional plan" with different measures aiming at improving nutritional status.
* a systematic drug review.

Conditions

  • Malnutrition
  • Polypharmacy
  • Aged

Interventions

DIETARY_SUPPLEMENT

Individualized plan for improvement of nutrition

For each participant we will make a plan, describing different items the can improve their nutritional status: enrichment of food, dental care,

DRUG

Systematic drug review

Consider altering medication list if the patient has symptoms that may be attributed to adverse drug effects, in particular side effects as nausea, dry mouth or loss of appetite, and if drug-drug interactions or drug-disease interactions are likely to occur. Recommended changes in patient's medication list will be presented for the family physician who will hold the final decision to implement the suggested adjustments.

Sponsors & Collaborators

  • The Norwegian Research Fund for General Practice

    collaborator UNKNOWN

  • University of Oslo

    lead OTHER

Principal Investigators

  • Straand Jørund, Professor · Institute of Health and Society, University of Oslo, Norway

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-24
Primary Completion
2023-07-31
Completion
2023-07-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04228900 on ClinicalTrials.gov